Aqualitas Inc. is a biotechnology and healthcare startup based in Canada. Founded in 2014, the company has positioned itself as a pioneering force in Canada’s emerging medical cannabis industry. Aqualitas prides itself on producing high-quality, terpene and cannabinoid-rich flowers grown organically, aligning with their unwavering reverence for nature and commitment to serving patients. Notably, the company operates a sustainable cultivation system powered by aquaponic science, featuring organic living soil and over 800 koi fish, resulting in healthy plants grown without the use of pesticides and chemical fertilizers. The most recent development for Aqualitas was a $2.07M Venture Round investment on 15 August 2018. This funding round was supported by Innovacorp and Green Acre Capital, signifying confidence from notable investors in the company's mission and potential for growth. The company also serves both the medical and adult-use markets internationally through a dynamic portfolio of in-house brands. Aqualitas’ commitment to sustainability, quality control, and customer service has positioned it as a noteworthy player in the cannabis industry, with the potential for significant future expansion and market influence.
No recent news or press coverage available for Aqualitas Inc..